• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Dr Bradstreet at the Treating Autism Conference 9th September 2012

Messages
12
Talking at the Treating Autism Conference 2012 (www.treatingautism.co.uk), Dr Bradstreet explains how he made the connection between HIV patients, GcMAF and autism, and how he uses GcMAF from First Immune . He has checked the process and quality control and describes their laboratory as a boutique laboratory. He satisfies himself as to the quality, sterility and activity of the GcMAF and this has also confirmed by Prof Ruggerio in Italy. His medical paper is currently under peer review and will be published as soon as this process is completed. This describes how the presence of nagalase creates a reduction of naturally occurring GcMAF and observed reduction of nagalase from injectable GcMAF. He then goes on to describe the levels of success he is seeing in the treatment of autism using First Immune GcMAF

Extract and full version are available to view here:

Google gcmaf dot eu Dr Bradstreet at the Treating Autism Conference 9th September 2012